Should I get tested for Ureaplasma?

Usually not. The European STI Guidelines Editorial Board concluded there is no evidence that detecting and treating Ureaplasma does more good than harm, and does not recommend routine testing or treatment of asymptomatic or symptomatic men and women. Carriage is common and most people never develop disease. If you have urogenital symptoms, a clinician will usually test for established causes such as chlamydia, gonorrhea, and Mycoplasma genitalium first.

Is Ureaplasma a sexually transmitted infection?

Ureaplasma can be passed through sexual contact and from mother to baby, but it behaves more like a common colonizer than a classic STI. It is found in many healthy, sexually active adults who have no symptoms, which is why guidelines advise against routine screening. A positive result on its own is not a diagnosis.

Can Ureaplasma affect pregnancy?

Ureaplasma species are the microorganisms most often isolated from the amniotic fluid and placentas of preterm deliveries, and they are associated with chorioamnionitis. However, many women carry Ureaplasma and have uncomplicated pregnancies, and researchers have not established that it causes these outcomes. If you are pregnant and have questions about a result, discuss it with your obstetric provider.

What is the difference between Ureaplasma urealyticum and Ureaplasma parvum?

They are the two Ureaplasma species found in humans. U. parvum was originally classified as a biovar of U. urealyticum before being recognized as a separate species. Both are commonly carried. In men, U. urealyticum rather than U. parvum has been associated with urethritis, but probably only when present at a high load.

Ureaplasma (U. urealyticum): Testing and Pregnancy Risks

Overview

Ureaplasma urealyticum is one of the smallest free-living bacteria known, and one of the most commonly detected organisms in the human lower urogenital tract. Together with its close relative Ureaplasma parvum, it belongs to the "genital mycoplasmas" — a group whose role in human disease has been debated for decades.

The central fact about Ureaplasma is that carriage is common and usually harmless. Much of the historical confusion about these organisms, as one major review notes, comes from their fastidious growth requirements, their high prevalence in healthy people, and poorly designed studies that equated the mere presence of the organism with disease.^[1] That context matters for anyone who has received a positive Ureaplasma result, often from a broad urogenital panel.

At the same time, Ureaplasma is not simply inert. It has been associated with urethritis in men when present at high loads, and it is the organism most frequently isolated from the amniotic fluid and placentas of preterm deliveries.^[2] Separating harmless colonization from genuine disease is the core clinical challenge.

Classification

Domain: Bacteria
Phylum: Mycoplasmatota (historically Tenericutes)
Family: Mycoplasmataceae
Genus: Ureaplasma
Human species: U. urealyticum and U. parvum

The genus name reflects its defining trait: Ureaplasma hydrolyzes urea to generate energy, an unusual metabolism among bacteria. Ureaplasmas were once called "T-strain mycoplasmas" for the tiny colonies they form in culture. U. parvum was originally described as a biovar of U. urealyticum before being recognized as a separate species, which is why older studies often report "U. urealyticum" for what may have been either organism.

Key Characteristics

No cell wall. Like all mycoplasmas, Ureaplasma lacks a peptidoglycan cell wall. A practical consequence is that beta-lactam antibiotics such as penicillin, which target cell-wall synthesis, have no effect on it.^[1]
Minimal genome. Its small genome leaves it dependent on its host for many nutrients, which is part of why it is difficult to grow in standard laboratory culture.
Urease activity. Urea hydrolysis produces ammonia, which can influence the local environment and contributes to its biology in the urinary tract.
Detection requires specialized methods. Routine bacterial cultures miss Ureaplasma; it is detected by specialized culture or, more commonly today, by nucleic acid amplification (PCR) tests.

Health Significance

Colonization versus disease

A 2018 position statement from the European STI Guidelines Editorial Board reviewed the evidence and concluded plainly: there is no evidence that detecting and treating Mycoplasma hominis, U. parvum, or U. urealyticum does more good than harm. Routine testing and treatment of asymptomatic or symptomatic men and women is therefore not recommended.^[3]

The same statement notes that asymptomatic carriage is common and that most people never develop disease. In men, U. urealyticum has been associated with urethritis, but it is probably not causal unless present at a high bacterial load.^[3] The board also cautioned that extensive testing and treatment may select for antimicrobial resistance — in Ureaplasma, in true STI pathogens, and in the wider microbiota — at substantial economic cost, a problem it says multiplex PCR panels that bundle these organisms with standard STI tests have made worse.^[3]

Pregnancy and newborns

The pregnancy literature is where Ureaplasma draws the most concern. Ureaplasma species are the microorganisms most frequently isolated from the amniotic fluid and placentas of women who deliver preterm, and they are associated with spontaneous miscarriage, neonatal respiratory disease, and chorioamnionitis (inflammation of the fetal membranes).^[2]

Yet the causal picture remains unresolved. Not all women who carry Ureaplasma develop chorioamnionitis, and researchers have not satisfactorily explained why the organism causes disease in some pregnancies and not others.^[2] Factors under study include bacterial load, strain-level differences, the host immune response, and the composition of the wider vaginal microbiome. In very premature infants, Ureaplasma has also been investigated as a contributor to chronic lung disease.^[1]

Ureaplasma and the Vaginal Microbiome

Ureaplasma does not live in isolation. Most healthy vaginal microbiomes are dominated by lactic-acid-producing Lactobacillus species, particularly Lactobacillus crispatus, which keep the environment acidic and resistant to colonization by other organisms. When that dominance breaks down, as in bacterial vaginosis with overgrowth of organisms such as Gardnerella vaginalis, the ecological niche for opportunists like Ureaplasma changes too.

This is one reason researchers increasingly study Ureaplasma as part of a community rather than as a lone pathogen. For practical guidance on supporting a Lactobacillus-dominant vaginal microbiome, see our guide to probiotics for vaginal health and the women's vaginal and urinary health protocol.

What a Positive Test Result Means

If a Ureaplasma result appeared on a broad urogenital panel, it helps to keep three points in mind:

A positive result is not a diagnosis. Carriage is common in people with no symptoms, and current European guidance does not recommend treating asymptomatic carriage.^[3]
Symptoms usually have other causes. Urethral or vaginal symptoms are more often due to established pathogens such as chlamydia, gonorrhea, Mycoplasma genitalium, or bacterial vaginosis, which should be evaluated first.
Pregnancy warrants a conversation, not alarm. The associations with preterm birth are real but not proven causal. Discuss any result with your obstetric provider rather than seeking treatment on your own.

When to See a Clinician

Seek care for urethral discharge, burning with urination, pelvic pain, abnormal vaginal discharge, or any symptoms during pregnancy. A clinician can test for the infections that most commonly cause these symptoms and decide whether a Ureaplasma result is relevant in your situation.

This page is for educational purposes and is not medical advice. Consult a qualified healthcare provider about test results or symptoms.

Ureaplasma urealyticum